Showing results (2951-2960 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 18, 2000
Pharmacoeconomic considerations in treating ovarian cancerD Bodurka-Bevers, C C Sun, D M GershensonPharmacoeconomics|August 18, 2000
The importance of achieving additional drug benefits at a reasonable cost. A review of the fluoxetine yearsN Freemantle, J MasonPharmacoeconomics|August 18, 2000
Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmineA B Hauber, A Gnanasakthy, E H Snyder, et al.Pharmacoeconomics|August 18, 2000
Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acidM Sculpher, M K Palmer, A HeyesPharmacoeconomics|August 18, 2000
Cost effectiveness of competing strategies to prevent or treat GORD-related dysphagiaA SonnenbergPharmacoeconomics|May 27, 1999
Development of an economic model for the management of upper gastrointestinal disease in primary care. Preliminary findingsA Haycox, M Butterworth, T Walley, et al.Pharmacoeconomics|May 27, 1999
Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal diseaseA Haycox, D Dubois, M ButterworthPharmacoeconomics|April 4, 2001
Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providersS D FindlayPharmacoeconomics|April 4, 2001
A review of health-related quality-of-life measures in strokeB A Golomb, B G Vickrey, R D HaysPageof 336